16th November 2022 | Pharma Updates

Latest pharmaceutical industry news and updates

*Refresh the page if the below document does not appear.

HC asks Maharashtra Govt. to re-examine J&J's baby powder samples

On Monday, the Bombay High Court directed the Maharashtra government to re-test the samples of baby powder marketed by Johnson and Johnson Private Limited. The order was passed by the authority while hearing a petition filed by the company against two orders issued by the authority earlier.

Deadly combination: Doctors and shady firms collaborate to make fake Cancer drugs

An MBBS from China’s Hubei University after working in many leading hospitals as a resident joined hands with a fellow medical student from Bangladesh to manufacture fake Cancer medicines by procuring APIs. The cops are still in search of the other members of the syndicate.

Nikon India brings microscopy solutions to the healthcare sector in Indian market

Nokia India has declared its entry into the healthcare sector with the product microscopy business. The leading camera manufacturing company aims to enable “direct sales, service, and distributions of their microscopy solutions” .

Indian pharma will benefit from research linked incentives: Biocon chairperson

Kiran Mazumdar-Shaw, Executive Chairperson of Biocon, and Biocon Biologics said that the government should come up with researchlinked incentives for the pharmaceutical industry to make sure the companies get themselves involved in innovative medicine and research.

US court declines Natco pharma's partner Alvogen's plea for Ibrutinib case

The US court has rejected the appeal of Natco Pharma’s marketing partner Alvogen’s appeal on the case of Ibrutinib tablets. The case was related to proposed generic equivalents to the Cancer drug Imbruvica tablets.

Entry hurdles for pharma companies in India is very low: Sanjiv Navangul

Sanjiv Navangul, Managing director and CEO of Bharat Vaccines and Serums mentioned that “India needs high-quality biotech companies as there are none or hardly any, and that their dream is to make high-quality biotech products and they are working on that” .

Karnataka CM emphasizes partnership with the US in pharma sector

Basavaraj Bommai, the Chief Minister of Karnataka highlighted the importance of setting up a working system between the US officials and Karnataka Government to increase pharma-related R&D development and as well as drug manufacturing in the state.

Update profile

Please update your profile to keep using the website

Start chat
Need Help?
PharmaState Academy
Hello, how can we help you?